Source: Eur Respir J 2002; 20: 440-443
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Quantrill S.J., Woodhead M.A., Bell C.E., Hardy C.C., Hutchison A.J., Gokal R.. Side-effects of antituberculosis drug treatment in patients with chronic renal failure. Eur Respir J 2002; 20: 440-443

Member's Comments

No comment yet.

Related content which might interest you: Impact of the duration of renal replacement therapy on the respiratory complications in patients with end-stage renal disease Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Biological parameters evolution in acute renal failure (ARF) patients treated with tuberculostatics drugs Source: Eur Respir J 2004; 24: Suppl. 48, 419s Year: 2004 Anti-TB aminoglycosides-induced renal failure – a series of 10 patients Source: Annual Congress 2007 - Difficult tuberculosis cases II Year: 2007 Tuberculosis in patients with chronic renal failure Source: Eur Respir J 2006; 28: Suppl. 50, 164s Year: 2006 Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Impact of hemodialysis on dyspnoea in chronic renal failure patients Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Antibiotic treatment and prophylaxis Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases Year: 2006 Effects of physiotherapy intervention in chronic renal failure patients during hemodialysis Source: Annual Congress 2010 - Exercise training: new groups, new methods and outcomes Year: 2010 Pleuro-pulmonary changes in patients suffering from end-stage renal disease receiving regular hemodialysis Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Specific features of acute renal failure in rifampicin treated patients for pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 609s Year: 2002 Impact of hemodialysis on dyspnoea and lung function in patients with chronic renal failure Source: Annual Congress 2008 - Lung function in respiratory disease Year: 2008 Acute renal failure due to continuous rifampicin therapy Source: Eur Respir J 2006; 28: Suppl. 50, 848s Year: 2006 Acute renal failure due to rifampicin during tuberculosis treatment Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 Why short-term antibiotic use in AECB may influence long-term outcomes Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Acute effects of early mobility and respiratory therapy in hospitalised patients with chronic heart failure Source: Annual Congress 2009 - Respiratory physiotherapy assessment Year: 2009 Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD Source: Eur Respir J 2009; 33: 282-288 Year: 2009 The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis Source: Eur Respir J 2001; 17: 928-933 Year: 2001